Sarepta Therapeutics (SRPT) Should Shut Up About Ebola And Focus On Job No. 1
8/7/2014 6:48:14 AM
By publicizing its outreach to the U.S. government about an experimental ebola treatment, Sarepta comes off looking like just another opportunistic, self-promoting drug developer. Sarepta isn't wrong to remind the U.S. government about the drug in its freezer which might be effective against the ebola virus, but why talk to the media about it?
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by